Nebenwirkungen · Azacitidine Accord
Azacitidine Accord 25 mg/mL powder for suspension for injection · Abschnitt 4.8 · PDF-Seite 7
HOS-293126 · Präparat HOS-287814
Adult population aged 65 years or older with AML with > 30% marrow blasts The most common serious adverse reactions (≥10%) noted from AZA-AML-001 within the azacitidine treatment arm included febrile neutropenia (25.0%), pneumonia (20.3%), and pyrexia (10.6%). Other less frequently reported serious adverse reactions in the azacitidine treatment arm included sepsis (5.1%), anaemia (4.2%), neutropenic sepsis (3.0%), urinary tract infection (3.0%), thrombocytopenia (2.5%), neutropenia (2.1%), cellulitis (2.1%), dizziness (2.1%) and dyspnoea (2.1%).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-11-07T16:48:00Z · SHA-256 908ef92f67d38ea0883a039ee7823201dc01f81c9207cf8ad2714da5b604cc61 · Passage e6fe47ecd98e74bc43929662958cdb8a5559ad93a93f916ae5a6e103309940ba · Zeichen 1194–1745 im Abschnitt